WHAD&P
  • HOME
  • WHAD&P
    • Mission
    • Statute
    • Board of Directors and International Committee
    • Application form
    • Site Registration Page
    • Annual Renewal 2026
  • EVENTS
    • Congresses and Conferences
      • Nationals
      • Internationals
      • FAD
    • Master
    • Training courses
  • NEWS
  • USEFUL LINKS
  • CONTACTS
Select a page

F Xiang, et al. Abstract #LBA-213. Presented at: European Academy of Dermatology and Venereology Congress; Sept. 17-20, 2025; Paris.

from admin | Oct 2, 2025 | News

F Xiang, et al. Abstract #LBA-213. Presented at: European Academy of Dermatology and Venereology Congress; Sept. 17-20, 2025; Paris. Denifanstat, a fatty acid synthase inhibitor, has been shown to be effective in the treatment of acne vulgaris caused by...

The FDA has approved Zoryve cream (roflumilast) 0.05% for the treatment of children aged 2 to 5 years with mild to moderate atopic dermatitis.

from admin | Oct 1, 2025 | News

The FDA has approved Zoryve cream (roflumilast) 0.05% for the treatment of children aged 2 to 5 years with mild to moderate atopic dermatitis. "Younger children with AD are children with specific medical needs," Dr. ... told Healio.

"The Association of Psoriasis and Bacterial Infections in Pediatric Patients: A Retrospective Review."

by admin | Jul 2, 2025 | News

Ravi M et al. Pediatric dermatology. 2025;42(4):735-741. https://doi.org/10.1111/pde.16007 Guttate psoriasis onset and plaque psoriasis flares are associated with streptococcal pharyngitis. Literature regarding the relationship between anogenital bacterial dermatitis...

"Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea: Two Phase 3 Randomized Clinical Trials."

by admin | Jul 2, 2025 | News

 Bhatia N et al. JAMA Dermatol. 2025;161(5):499. Low-dose doxycycline is an established treatment for papulopustular features of rosacea that may reduce the adverse effects of doxycycline treatment; however, data on low-dose regimens for other tetracyclines are...

The FDA issued a warning about risk for severe itching after stopping long-term allergy medication use (cetirizine...)

by admin | Jul 2, 2025 | News

The FDA issued a warning about risk for severe itching after stopping long-term allergy medication use (cetirizine...) as well as updated prescribing information stating the symptoms may improve when restarting the...
" Previous Posts
Next Posts "

World Health Academy of Dermatology and Pediatrics ETS
Via Flaminia Nuova, 1068
Rome, 00189
Tax ID 96436240582
Email:info@whadandp.com

Designed by Zerounoprojects info@zerounoprojects.it
  • Italiano